BOLT Earnings Bolt Biotherapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–19 of 19
| Q1 2026 | 2026-03-31 | -4.31 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -17.85 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -13.94 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -10.22 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -5.76 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -33.06 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -24.73 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -16.80 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.28 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -1.83 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -1.36 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.93 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.45 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -2.36 | 2024-03-21 | 10-K |
| Q3 2023 | 2022-09-30 | -1.83 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.25 | 2023-08-07 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.64 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -2.97 | 2023-03-29 | 10-K |
| Q3 2022 | 2021-09-30 | -2.24 | 2022-11-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.